Surat, June 13, 2023: Anupam Rasayan (NSE, BSE: ANURAS), one of India’s leading custom synthesis & speciality chemical players, has signed Letter of Intent worth revenue of $265 Mn (₹2,186 crores) for next 5 years with one of the leading Japanese Speciality Chemical company to supply new age patented life science active ingredient. The product will be in validation phase for the next eighteen months and upon the successful validation, the supply will commence from CY2025. This product will be manufactured in our existing multipurpose manufacturing facilities.
Speaking about the contract, Anand Desai, Managing Director of Anupam Rasayan, said, “We are pleased to announce that we will be the primary global supplier of this new age patented life science active ingredient to one of the leading Japanese specialty chemical companies with the support of our Japanese business development team. With the addition of this new customer, we are delighted to include another renowned Japanese multinational in our customer portfolio. As we are fully backward integrated for this molecule, we can provide supply chain assurance to the customer without dependencies on supplies from other geographies.”
“The signing of this LOI represents a significant milestone for us, further cementing our position as a trusted provider of high-end customized molecules. We are excited about the opportunities this partnership brings.”
About Anupam Rasayan India Ltd. (ARIL):
Anupam Rasayan India Ltd (ARIL) is one of the leading companies engaged in the custom synthesis (CSM) and manufacturing of specialty chemicals in India. Incorporated in 1984, the speciality chemicals major has two verticals: Life science related Specialty Chemicals comprising products related to Agrochemicals, Personal Care and Pharmaceuticals, Other Specialty Chemicals comprising Specialty Pigment and Dyes, and Polymer Additives.
The Company caters to a diverse base of Indian and global customers. It is currently manufacturing products for over 71 domestic and international customers, including 27 multinational companies. The Company operates via its six manufacturing facilities in Gujarat, India, with four facilities located at Sachin, Surat and two located at Jhaghadia, Bharuch with an aggregate installed capacity of about 27,000 MT as of 31st December 2022. ARIL offers multistep synthesis and undertakes complex chemical reactions technologies, for a diverse base of Indian and global customers.
No comments:
Post a Comment